Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACHL |
---|---|---|
09:32 ET | 1000 | 0.975 |
09:36 ET | 890 | 0.977 |
09:45 ET | 3045 | 0.9764 |
10:10 ET | 2131 | 0.9764 |
10:12 ET | 100 | 0.9903 |
10:14 ET | 100 | 0.9903 |
10:24 ET | 100 | 0.9903 |
10:26 ET | 1742 | 0.98 |
10:33 ET | 100 | 0.9903 |
10:39 ET | 3100 | 0.9851 |
10:42 ET | 100 | 0.9812 |
10:48 ET | 100 | 1 |
10:55 ET | 200 | 0.9979 |
11:09 ET | 3047 | 0.993 |
11:11 ET | 200 | 0.99307 |
11:13 ET | 1900 | 0.99305 |
11:24 ET | 1000 | 0.993 |
11:40 ET | 400 | 0.99 |
12:12 ET | 398 | 0.9902 |
12:18 ET | 100 | 0.9902 |
12:27 ET | 2700 | 0.9882 |
12:30 ET | 100 | 0.9931 |
12:41 ET | 100 | 1 |
01:12 ET | 100 | 1 |
01:19 ET | 220 | 0.9857 |
01:21 ET | 600 | 0.9856 |
01:26 ET | 100 | 1 |
01:30 ET | 170 | 0.987 |
01:32 ET | 18975 | 0.987 |
01:33 ET | 550 | 0.987 |
01:42 ET | 101 | 1 |
01:44 ET | 100 | 1 |
01:46 ET | 12345 | 0.9985 |
01:57 ET | 100 | 1.01 |
02:06 ET | 100 | 1.01 |
02:11 ET | 1659 | 1.01 |
02:15 ET | 8000 | 1.01 |
02:20 ET | 100 | 1.02 |
02:24 ET | 100 | 1.02 |
02:27 ET | 100 | 1.02 |
02:29 ET | 10000 | 1 |
02:33 ET | 100 | 1.01 |
02:47 ET | 100 | 1.02 |
02:51 ET | 100 | 1.02 |
02:56 ET | 100 | 1.02 |
02:58 ET | 100 | 1.02 |
03:02 ET | 100 | 1.02 |
03:05 ET | 100 | 1.02 |
03:09 ET | 100 | 1.02 |
03:12 ET | 500 | 1.02 |
03:16 ET | 100 | 1.02 |
03:20 ET | 100 | 1.02 |
03:21 ET | 616 | 1.02 |
03:25 ET | 100 | 1.02 |
03:27 ET | 401 | 1.02 |
03:34 ET | 1581 | 1.01 |
03:36 ET | 100 | 1.02 |
03:38 ET | 819 | 1.02 |
03:39 ET | 100 | 1.02 |
03:41 ET | 100 | 1.02 |
03:43 ET | 100 | 1.02 |
03:45 ET | 100 | 1.02 |
03:48 ET | 200 | 1.02 |
03:50 ET | 100 | 1.02 |
03:52 ET | 508 | 1.02 |
03:54 ET | 200 | 1.02 |
03:56 ET | 200 | 1.02 |
03:57 ET | 701 | 1.01 |
03:59 ET | 3901 | 1.02 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Achilles Therapeutics PLC | 41.9M | -0.6x | --- |
vTv Therapeutics Inc | 42.7M | -2.1x | --- |
HST Global Inc | 43.2M | -49.8x | --- |
Reviva Pharmaceuticals Holdings, Inc. | 40.4M | -0.9x | --- |
Estrella Immunopharma Inc | 40.2M | -0.6x | --- |
Aeon Biopharma Inc | 43.9M | -0.1x | --- |
Achilles Therapeutics plc is a United Kingdom-based clinical-stage immuno-oncology biopharmaceutical company. The Company is engaged in developing precision T cell therapies to treat multiple types of solid tumors. Its lead product is a precision tumor-derived T cell therapy targeting clonal cancer neoantigens. Its pipeline includes Chiron: Advanced Non-Small Cell Lung Cancer, Thetis: Melanoma (Monotherapy), Thetis: Melanoma (PD-1 Combination), and other indications. It is focused on advancing cancer therapies through its work in the field of tumor evolution. Its platform enables to identify mutations formed early in the development of a cancer that give rise to antigens that are expressed by all of a patient's cancer cells but are absent from healthy tissue. It refers to this class of solid tumor targets as clonal neoantigens. To identify clonal neoantigens in a patient, it has developed a bioinformatic platform called PELEUS.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $41.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 41.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.34 |
EPS | $-1.59 |
Book Value | $3.47 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.